Syed Hasan

Syed Hasan serves as an Honorary Senior Clinical Lecturer within the Division of Diabetes, Endocrinology and Gastroenterology, maintaining a formal academic affiliation centered on clinical research and education in gastroenterology. His active role in accepting PhD students underscores his commitment to mentoring the next generation of researchers in functional gastrointestinal disorders.

Dr. Hasan's research is predominantly focused on gut-directed hypnotherapy for refractory irritable bowel syndrome (IBS), investigating critical factors such as symptom severity, extraintestinal manifestations, and cultural variables—including efficacy in Asian populations. His work extends to pandemic-era challenges, examining remote therapy delivery, patient satisfaction, and the evolving symptom burden of IBS in tertiary care settings, thereby advancing mind-body interventions in clinical gastroenterology.

Analysis of his 2021-2024 publications reveals a strategic shift toward digital therapeutics and telehealth solutions for hypnotherapy, driven by pandemic exigencies. Key trends include optimizing remote delivery protocols, addressing health disparities across ethnic groups, identifying predictive biomarkers for treatment response, and developing mobile applications to enhance accessibility—collectively paving the way for personalized, culturally competent IBS management.

Dr. Hasan actively mentors PhD students and collaborates extensively with international researchers like P.J. Whorwell and D.H. Vasant. His multi-institutional projects, including randomized controlled trials on hypnotherapy efficacy, suggest robust grant funding for clinical investigations into functional gastrointestinal disorders, though specific grant details remain undisclosed in available materials.